Parkinson's Digest
  • All
  • Research
  • Trials
  • News
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Trial Phase 3 Recruiting June 4, 2026
Understanding Motivation in Parkinson's Patients Through Neurophysiology
Trial N/A Recruiting June 4, 2026
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Trial Phase 2 Not yet recruiting June 4, 2026
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
Trial Phase 1 Recruiting June 4, 2026
A Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
Trial Phase 2 Not yet recruiting June 4, 2026
Remote Haptic Rehabilitation for Parkinson's Disease
Trial N/A Recruiting June 4, 2026
5 common misconceptions about Parkinson’s disease
News Parkinson's News Today – The Web's Daily Resource for Parkinson's News June 4, 2026
Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension
News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents June 4, 2026
Aligning incentives for open science in biomedical research: Navigating funder and institutional perspectives *
News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents June 4, 2026
MJFF backs protein-targeting Parkinson’s therapy with $3.4M grant
News Parkinson's News Today – The Web's Daily Resource for Parkinson's News June 4, 2026
Falls Induced by Optogenetic Inhibition of Basal Forebrain Cholinergic Projections after Dorsomedial Striatal Dopamine Depletion in a Dual Disruption Model of Falling Vulnerability in Parkinson Disease.
Research bioRxiv : the preprint server for biology June 4, 2026
D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression
Trial Phase 2 Recruiting June 3, 2026
Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease
Trial N/A Not yet recruiting June 3, 2026
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Trial Phase 3 Recruiting June 3, 2026
A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80
Trial Phase 2 Completed June 3, 2026
Blood Flow Restriction and Exercise in Parkinson's Disease
Trial N/A Completed June 3, 2026
The Meals Study for Amyotrophic Lateral Sclerosis and Parkinson's Disease
Trial N/A Completed June 3, 2026
Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease
Trial N/A Recruiting June 3, 2026
Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease
Trial N/A Recruiting June 3, 2026
Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease
Trial Phase 4 Not yet recruiting June 3, 2026
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest